Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Oruka Therapeutics, Inc. | 236,384 | reported | 15 Jun 2026 | tx 14+197,500−29,200 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Jun 2026 | SALE | Oruka Therapeutics, Inc. | 600 | 69.69 USD | |
| 16 Mar 2026 | SALE | Oruka Therapeutics, Inc. | 600 | 41.30 USD | |
| 02 Mar 2026 | EXERCISE | Oruka Therapeutics, Inc. | 5,000 | 7.80 USD | |
| 02 Mar 2026 | SALE | Oruka Therapeutics, Inc. | 2,325 | 33.28 USD | |
| 02 Mar 2026 | SALE | Oruka Therapeutics, Inc. | 2,675 | 33.81 USD | |
| 02 Mar 2026 | EXERCISE | Oruka Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 23 Jan 2026 | GRANT_AWARD | Oruka Therapeutics, Inc. | 32,500 | 0.00 USD | |
| 23 Jan 2026 | GRANT_AWARD | Oruka Therapeutics, Inc. | 130,000 | 0.00 USD | deriv |
| 02 Jan 2026 | EXERCISE | Oruka Therapeutics, Inc. | 5,000 | 7.80 USD | |
| 02 Jan 2026 | SALE | Oruka Therapeutics, Inc. | 8,748 | 28.17 USD | |
| 02 Jan 2026 | SALE | Oruka Therapeutics, Inc. | 3,144 | 29.08 USD | |
| 02 Jan 2026 | SALE | Oruka Therapeutics, Inc. | 1,108 | 29.75 USD | |
| 02 Jan 2026 | EXERCISE | Oruka Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 01 Jul 2025 | GRANT_AWARD | Oruka Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |